BioOrbit
In-space drug manufacturing platform for large-scale crystallization of protein drugs in microgravity
B2X
CEO
Country
Email Address
info@bioorbit.com
Founded Date
2023
Founder
Headquarters
Latest Funding Round Date
April 30, 2026
Latest Funding Round Amount (USD)
13,400,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
13,400,000
Official Website
Find more companies like BioOrbit
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.